Sterling Investment Advisors, Ltd. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Sterling Investment Advisors, Ltd. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$228,119
+12.3%
5,0070.0%0.08%
+10.3%
Q1 2023$203,084
-38.5%
5,007
-22.7%
0.07%
-42.4%
Q4 2022$330,031
-5.4%
6,4750.0%0.12%
-9.9%
Q3 2022$349,000
-16.1%
6,4750.0%0.13%
-8.4%
Q2 2022$416,000
-17.1%
6,4750.0%0.14%
+0.7%
Q1 2022$502,000
-14.8%
6,475
-5.6%
0.14%
-14.5%
Q4 2021$589,000
-1.0%
6,861
-7.2%
0.17%
-6.2%
Q3 2021$595,000
-10.5%
7,395
-10.5%
0.18%
-9.2%
Q2 2021$665,000
-17.3%
8,263
-13.3%
0.20%
-24.7%
Q1 2021$804,000
+1.1%
9,527
-3.9%
0.26%
-4.1%
Q4 2020$795,000
-0.3%
9,9120.0%0.27%
-12.1%
Q3 2020$797,000
-6.6%
9,9120.0%0.31%
-13.3%
Q2 2020$853,000
+12.1%
9,912
+5.7%
0.35%
-11.9%
Q1 2020$761,000
-2.9%
9,3780.0%0.40%
+11.7%
Q4 2019$784,000
-9.0%
9,378
-4.9%
0.36%
-18.2%
Q3 2019$862,000
+2.7%
9,860
-3.8%
0.44%
+2.6%
Q2 2019$839,000
-2.1%
10,246
-2.8%
0.43%
-1.8%
Q1 2019$857,000
+23.5%
10,5460.0%0.44%
+7.1%
Q4 2018$694,000
-14.6%
10,5460.0%0.41%
-4.4%
Q3 2018$813,000
+4.5%
10,5460.0%0.43%
-7.0%
Q2 2018$778,000
+13.4%
10,5460.0%0.46%
+9.0%
Q1 2018$686,000
+0.6%
10,5460.0%0.42%
-0.5%
Q4 2017$682,000
+3.0%
10,5460.0%0.42%
-3.6%
Q3 2017$662,000
-3.5%
10,546
-6.9%
0.44%
-4.1%
Q2 2017$686,000
+13.0%
11,325
-3.3%
0.46%
+5.0%
Q1 2017$607,000
+5.9%
11,711
-9.4%
0.44%
-5.0%
Q4 2016$573,00012,9270.46%
Other shareholders
BAXTER INTL INC shareholders Q3 2019
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders